APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cell and Gene Therapy Supply Chain and Logistics

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cell and Gene Therapy Supply Chain and Logistics Industry Growth and Trends Forecast to 2032

11 April 2026112 pages

Choose your research edition.

Industry ResearchCell and Gene Therapy Supply Chain and Logistics Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Cell and Gene Therapy Supply Chain and Logistics Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Cell and Gene Therapy Supply Chain and Logistics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cell and Gene Therapy Supply Chain and Logistics Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Cell and Gene Therapy Supply Chain and Logistics Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

According to APO Research, the global Cell and Gene Therapy Supply Chain and Logistics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cell and Gene Therapy Supply Chain and Logistics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cell and Gene Therapy Supply Chain and Logistics is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cell and Gene Therapy Supply Chain and Logistics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Cell and Gene Therapy Supply Chain and Logistics market include Be The Match BioTherapies, Biocair, Marken, World Courier, MAK-SYSTEM, Cryoport, Brooks Life Sciences, Hypertrust Patient Data Care and Haemonetics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cell and Gene Therapy Supply Chain and Logistics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cell and Gene Therapy Supply Chain and Logistics market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cell and Gene Therapy Supply Chain and Logistics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cell and Gene Therapy Supply Chain and Logistics.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Cell and Gene Therapy Supply Chain and Logistics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cell and Gene Therapy Supply Chain and Logistics Market by Company

Be The Match BioTherapies

Biocair

Marken

World Courier

MAK-SYSTEM

Cryoport

Brooks Life Sciences

Hypertrust Patient Data Care

Haemonetics

MasterControl

TraceLink

TrakCel

Stafa Cellular Therapy

McKesson

BioLife Solutions

Patheon

SF Express

Cell and Gene Therapy Supply Chain and Logistics Segment by Type

Ordering and Scheduling Services

Sample Collection Services

Logistics Services

Post Treatment Follow-Up Services

Cell and Gene Therapy Supply Chain and Logistics Segment by Application

Biobank

Cell Therapy Lab

Hospital

Research Institute

Cell and Gene Therapy Supply Chain and Logistics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell and Gene Therapy Supply Chain and Logistics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cell and Gene Therapy Supply Chain and Logistics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell and Gene Therapy Supply Chain and Logistics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Cell and Gene Therapy Supply Chain and Logistics companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Cell and Gene Therapy Supply Chain and Logistics Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Cell and Gene Therapy Supply Chain and Logistics Market Share by Region (2021-2026) Table 4. Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Cell and Gene Therapy Supply Chain and Logistics Market Share by Region (2027-2032) Table 6. Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Cell and Gene Therapy Supply Chain and Logistics Market Size Share by Type (2021-2026) Table 9. Global Cell and Gene Therapy Supply Chain and Logistics Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Cell and Gene Therapy Supply Chain and Logistics Market Size Share Forecasted by Type (2027-2032) Table 11. North America Cell and Gene Therapy Supply Chain and Logistics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Cell and Gene Therapy Supply Chain and Logistics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Cell and Gene Therapy Supply Chain and Logistics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Cell and Gene Therapy Supply Chain and Logistics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Cell and Gene Therapy Supply Chain and Logistics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Cell and Gene Therapy Supply Chain and Logistics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Cell and Gene Therapy Supply Chain and Logistics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Cell and Gene Therapy Supply Chain and Logistics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Cell and Gene Therapy Supply Chain and Logistics Market Size Share by Application (2021-2026) Table 24. Global Cell and Gene Therapy Supply Chain and Logistics Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Cell and Gene Therapy Supply Chain and Logistics Market Size Share Forecasted by Application (2027-2032) Table 26. North America Cell and Gene Therapy Supply Chain and Logistics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Cell and Gene Therapy Supply Chain and Logistics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Cell and Gene Therapy Supply Chain and Logistics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Cell and Gene Therapy Supply Chain and Logistics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Cell and Gene Therapy Supply Chain and Logistics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Cell and Gene Therapy Supply Chain and Logistics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Cell and Gene Therapy Supply Chain and Logistics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Cell and Gene Therapy Supply Chain and Logistics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Cell and Gene Therapy Supply Chain and Logistics Industry Trends Table 37. Cell and Gene Therapy Supply Chain and Logistics Industry Drivers Table 38. Cell and Gene Therapy Supply Chain and Logistics Industry Opportunities and Challenges Table 39. Cell and Gene Therapy Supply Chain and Logistics Industry Restraints Table 40. Global Cell and Gene Therapy Supply Chain and Logistics Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share by Company (2021-2026) Table 42. Global Cell and Gene Therapy Supply Chain and Logistics Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Cell and Gene Therapy Supply Chain and Logistics Key Company Headquarters & Area Served Table 44. Global Cell and Gene Therapy Supply Chain and Logistics Company, Product Type & Application Table 45. Global Cell and Gene Therapy Supply Chain and Logistics Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Cell and Gene Therapy Supply Chain and Logistics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Be The Match BioTherapies Company Information Table 49. Be The Match BioTherapies Business Overview Table 50. Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 52. Be The Match BioTherapies Recent Development Table 53. Biocair Company Information Table 54. Biocair Business Overview Table 55. Biocair Cell and Gene Therapy Supply Chain and Logistics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Biocair Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 57. Biocair Recent Development Table 58. Marken Company Information Table 59. Marken Business Overview Table 60. Marken Cell and Gene Therapy Supply Chain and Logistics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Marken Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 62. Marken Recent Development Table 63. World Courier Company Information Table 64. World Courier Business Overview Table 65. World Courier Cell and Gene Therapy Supply Chain and Logistics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. World Courier Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 67. World Courier Recent Development Table 68. MAK-SYSTEM Company Information Table 69. MAK-SYSTEM Business Overview Table 70. MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 72. MAK-SYSTEM Recent Development Table 73. Cryoport Company Information Table 74. Cryoport Business Overview Table 75. Cryoport Cell and Gene Therapy Supply Chain and Logistics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Cryoport Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 77. Cryoport Recent Development Table 78. Brooks Life Sciences Company Information Table 79. Brooks Life Sciences Business Overview Table 80. Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 82. Brooks Life Sciences Recent Development Table 83. Hypertrust Patient Data Care Company Information Table 84. Hypertrust Patient Data Care Business Overview Table 85. Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 87. Hypertrust Patient Data Care Recent Development Table 88. Haemonetics Company Information Table 89. Haemonetics Business Overview Table 90. Haemonetics Cell and Gene Therapy Supply Chain and Logistics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Haemonetics Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 92. Haemonetics Recent Development Table 93. MasterControl Company Information Table 94. MasterControl Business Overview Table 95. MasterControl Cell and Gene Therapy Supply Chain and Logistics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. MasterControl Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 97. MasterControl Recent Development Table 98. TraceLink Company Information Table 99. TraceLink Business Overview Table 100. TraceLink Cell and Gene Therapy Supply Chain and Logistics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. TraceLink Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 102. TraceLink Recent Development Table 103. TrakCel Company Information Table 104. TrakCel Business Overview Table 105. TrakCel Cell and Gene Therapy Supply Chain and Logistics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. TrakCel Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 107. TrakCel Recent Development Table 108. Stafa Cellular Therapy Company Information Table 109. Stafa Cellular Therapy Business Overview Table 110. Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 112. Stafa Cellular Therapy Recent Development Table 113. McKesson Company Information Table 114. McKesson Business Overview Table 115. McKesson Cell and Gene Therapy Supply Chain and Logistics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. McKesson Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 117. McKesson Recent Development Table 118. BioLife Solutions Company Information Table 119. BioLife Solutions Business Overview Table 120. BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 122. BioLife Solutions Recent Development Table 123. Patheon Company Information Table 124. Patheon Business Overview Table 125. Patheon Cell and Gene Therapy Supply Chain and Logistics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Patheon Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 127. Patheon Recent Development Table 128. SF Express Company Information Table 129. SF Express Business Overview Table 130. SF Express Cell and Gene Therapy Supply Chain and Logistics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. SF Express Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 132. SF Express Recent Development Table 133. North America Cell and Gene Therapy Supply Chain and Logistics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. North America Cell and Gene Therapy Supply Chain and Logistics Market Size by Country (2021-2026) & (US$ Million) Table 135. North America Cell and Gene Therapy Supply Chain and Logistics Market Share by Country (2021-2026) Table 136. North America Cell and Gene Therapy Supply Chain and Logistics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. North America Cell and Gene Therapy Supply Chain and Logistics Market Share Forecast by Country (2027-2032) Table 138. Europe Cell and Gene Therapy Supply Chain and Logistics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Europe Cell and Gene Therapy Supply Chain and Logistics Market Size by Country (2021-2026) & (US$ Million) Table 140. Europe Cell and Gene Therapy Supply Chain and Logistics Market Share by Country (2021-2026) Table 141. Europe Cell and Gene Therapy Supply Chain and Logistics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Europe Cell and Gene Therapy Supply Chain and Logistics Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Market Share by Country (2021-2026) Table 146. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Market Share Forecast by Country (2027-2032) Table 148. Latin America Cell and Gene Therapy Supply Chain and Logistics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Latin America Cell and Gene Therapy Supply Chain and Logistics Market Size by Country (2021-2026) & (US$ Million) Table 150. Latin America Cell and Gene Therapy Supply Chain and Logistics Market Share by Country (2021-2026) Table 151. Latin America Cell and Gene Therapy Supply Chain and Logistics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Latin America Cell and Gene Therapy Supply Chain and Logistics Market Share Forecast by Country (2027-2032) Table 153. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Size by Country (2021-2026) & (US$ Million) Table 155. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Share by Country (2021-2026) Table 156. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Share Forecast by Country (2027-2032) Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Cell and Gene Therapy Supply Chain and Logistics Product Image Figure 3. Global Cell and Gene Therapy Supply Chain and Logistics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Cell and Gene Therapy Supply Chain and Logistics Market Size (2021-2032) & (US$ Million) Figure 5. Global Cell and Gene Therapy Supply Chain and Logistics Market Share by Region: 2025 VS 2032 Figure 6. Global Cell and Gene Therapy Supply Chain and Logistics Market Share by Region (2021-2032) Figure 7. North America Cell and Gene Therapy Supply Chain and Logistics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Cell and Gene Therapy Supply Chain and Logistics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Cell and Gene Therapy Supply Chain and Logistics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Ordering and Scheduling Services Image Figure 13. Global Ordering and Scheduling Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Sample Collection Services Image Figure 15. Global Sample Collection Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Logistics Services Image Figure 17. Global Logistics Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Post Treatment Follow-Up Services Image Figure 19. Global Post Treatment Follow-Up Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Cell and Gene Therapy Supply Chain and Logistics Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Cell and Gene Therapy Supply Chain and Logistics Market Share by Type 2025 VS 2032 Figure 22. North America Cell and Gene Therapy Supply Chain and Logistics Market Size Share by Type (2021-2032) Figure 23. Europe Cell and Gene Therapy Supply Chain and Logistics Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Market Size Share by Type (2021-2032) Figure 25. Latin America Cell and Gene Therapy Supply Chain and Logistics Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Cell and Gene Therapy Supply Chain and Logistics Market Size Share by Type (2021-2032) Figure 27. Biobank Image Figure 28. Global Biobank Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Cell Therapy Lab Image Figure 30. Global Cell Therapy Lab Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Hospital Image Figure 32. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Research Institute Image Figure 34. Global Research Institute Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Cell and Gene Therapy Supply Chain and Logistics Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Cell and Gene Therapy Supply Chain and Logistics Market Share by Application 2025 VS 2032 Figure 37. North America Cell and Gene Therapy Supply Chain and Logistics Market Size Share by Application (2021-2032) Figure 38. Europe Cell and Gene Therapy Supply Chain and Logistics Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Market Size Share by Application (2021-2032) Figure 40. Latin America Cell and Gene Therapy Supply Chain and Logistics Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Cell and Gene Therapy Supply Chain and Logistics Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Cell and Gene Therapy Supply Chain and Logistics Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Cell and Gene Therapy Supply Chain and Logistics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Cell and Gene Therapy Supply Chain and Logistics Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Cell and Gene Therapy Supply Chain and Logistics Market Share by Country (2021-2032) Figure 47. Europe Cell and Gene Therapy Supply Chain and Logistics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Cell and Gene Therapy Supply Chain and Logistics Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Cell and Gene Therapy Supply Chain and Logistics Market Share by Country (2021-2032) Figure 50. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Market Share by Country (2021-2032) Figure 53. Latin America Cell and Gene Therapy Supply Chain and Logistics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Cell and Gene Therapy Supply Chain and Logistics Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Cell and Gene Therapy Supply Chain and Logistics Market Share by Country (2021-2032) Figure 56. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Ordering and Scheduling Services
  • Sample Collection Services
  • Logistics Services
  • Post Treatment Follow-Up Services
Applications
  • Biobank
  • Cell Therapy Lab
  • Hospital
  • Research Institute
Companies covered
  • Be The Match BioTherapies
  • Biocair
  • Marken
  • World Courier
  • MAK-SYSTEM
  • Cryoport
  • Brooks Life Sciences
  • Hypertrust Patient Data Care
  • Haemonetics
  • MasterControl
  • TraceLink
  • TrakCel
  • Stafa Cellular Therapy
  • McKesson
  • BioLife Solutions
  • Patheon
  • SF Express

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Cell and Gene Therapy Supply Chain and Logistics Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Region (2021-2032)
  5. 1.4.1 Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Region (2021-2026)
  6. 1.4.2 Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Region (2027-2032)
  7. 1.5 Key Regions Cell and Gene Therapy Supply Chain and Logistics Market Size (2021-2032)
  8. 1.5.1 North America Cell and Gene Therapy Supply Chain and Logistics Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Cell and Gene Therapy Supply Chain and Logistics Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Cell and Gene Therapy Supply Chain and Logistics Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Size Growth Rate (2021-2032)
2 Cell and Gene Therapy Supply Chain and Logistics Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Ordering and Scheduling Services
  3. 2.1.2 Sample Collection Services
  4. 2.1.3 Logistics Services
  5. 2.1.4 Post Treatment Follow-Up Services
  6. 2.2 Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Type
  7. 2.2.1 Global Cell and Gene Therapy Supply Chain and Logistics Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Cell and Gene Therapy Supply Chain and Logistics Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Cell and Gene Therapy Supply Chain and Logistics Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Regions
  11. 2.3.1 North America Cell and Gene Therapy Supply Chain and Logistics Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Cell and Gene Therapy Supply Chain and Logistics Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Cell and Gene Therapy Supply Chain and Logistics Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Cell and Gene Therapy Supply Chain and Logistics Market Size Breakdown by Type (2021-2026)
3 Cell and Gene Therapy Supply Chain and Logistics Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Biobank
  3. 3.1.2 Cell Therapy Lab
  4. 3.1.3 Hospital
  5. 3.1.4 Research Institute
  6. 3.2 Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Application
  7. 3.2.1 Global Cell and Gene Therapy Supply Chain and Logistics Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Cell and Gene Therapy Supply Chain and Logistics Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Cell and Gene Therapy Supply Chain and Logistics Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Regions
  11. 3.3.1 North America Cell and Gene Therapy Supply Chain and Logistics Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Cell and Gene Therapy Supply Chain and Logistics Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Cell and Gene Therapy Supply Chain and Logistics Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Cell and Gene Therapy Supply Chain and Logistics Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Cell and Gene Therapy Supply Chain and Logistics Industry Trends
  2. 4.2 Cell and Gene Therapy Supply Chain and Logistics Industry Drivers
  3. 4.3 Cell and Gene Therapy Supply Chain and Logistics Industry Opportunities and Challenges
  4. 4.4 Cell and Gene Therapy Supply Chain and Logistics Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Cell and Gene Therapy Supply Chain and Logistics Revenue (2021-2026)
  2. 5.2 Global Cell and Gene Therapy Supply Chain and Logistics Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Cell and Gene Therapy Supply Chain and Logistics Key Company Headquarters & Area Served
  4. 5.4 Global Cell and Gene Therapy Supply Chain and Logistics Company, Product Type & Application
  5. 5.5 Global Cell and Gene Therapy Supply Chain and Logistics Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Cell and Gene Therapy Supply Chain and Logistics Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Cell and Gene Therapy Supply Chain and Logistics Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Cell and Gene Therapy Supply Chain and Logistics Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Be The Match BioTherapies
  2. 6.1.1 Be The Match BioTherapies Company Information
  3. 6.1.2 Be The Match BioTherapies Business Overview
  4. 6.1.3 Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  6. 6.1.5 Be The Match BioTherapies Recent Developments
  7. 6.2 Biocair
  8. 6.2.1 Biocair Company Information
  9. 6.2.2 Biocair Business Overview
  10. 6.2.3 Biocair Cell and Gene Therapy Supply Chain and Logistics Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Biocair Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  12. 6.2.5 Biocair Recent Developments
  13. 6.3 Marken
  14. 6.3.1 Marken Company Information
  15. 6.3.2 Marken Business Overview
  16. 6.3.3 Marken Cell and Gene Therapy Supply Chain and Logistics Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Marken Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  18. 6.3.5 Marken Recent Developments
  19. 6.4 World Courier
  20. 6.4.1 World Courier Company Information
  21. 6.4.2 World Courier Business Overview
  22. 6.4.3 World Courier Cell and Gene Therapy Supply Chain and Logistics Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 World Courier Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  24. 6.4.5 World Courier Recent Developments
  25. 6.5 MAK-SYSTEM
  26. 6.5.1 MAK-SYSTEM Company Information
  27. 6.5.2 MAK-SYSTEM Business Overview
  28. 6.5.3 MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  30. 6.5.5 MAK-SYSTEM Recent Developments
  31. 6.6 Cryoport
  32. 6.6.1 Cryoport Company Information
  33. 6.6.2 Cryoport Business Overview
  34. 6.6.3 Cryoport Cell and Gene Therapy Supply Chain and Logistics Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Cryoport Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  36. 6.6.5 Cryoport Recent Developments
  37. 6.7 Brooks Life Sciences
  38. 6.7.1 Brooks Life Sciences Company Information
  39. 6.7.2 Brooks Life Sciences Business Overview
  40. 6.7.3 Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  42. 6.7.5 Brooks Life Sciences Recent Developments
  43. 6.8 Hypertrust Patient Data Care
  44. 6.8.1 Hypertrust Patient Data Care Company Information
  45. 6.8.2 Hypertrust Patient Data Care Business Overview
  46. 6.8.3 Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  48. 6.8.5 Hypertrust Patient Data Care Recent Developments
  49. 6.9 Haemonetics
  50. 6.9.1 Haemonetics Company Information
  51. 6.9.2 Haemonetics Business Overview
  52. 6.9.3 Haemonetics Cell and Gene Therapy Supply Chain and Logistics Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Haemonetics Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  54. 6.9.5 Haemonetics Recent Developments
  55. 6.10 MasterControl
  56. 6.10.1 MasterControl Company Information
  57. 6.10.2 MasterControl Business Overview
  58. 6.10.3 MasterControl Cell and Gene Therapy Supply Chain and Logistics Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 MasterControl Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  60. 6.10.5 MasterControl Recent Developments
  61. 6.11 TraceLink
  62. 6.11.1 TraceLink Company Information
  63. 6.11.2 TraceLink Business Overview
  64. 6.11.3 TraceLink Cell and Gene Therapy Supply Chain and Logistics Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 TraceLink Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  66. 6.11.5 TraceLink Recent Developments
  67. 6.12 TrakCel
  68. 6.12.1 TrakCel Company Information
  69. 6.12.2 TrakCel Business Overview
  70. 6.12.3 TrakCel Cell and Gene Therapy Supply Chain and Logistics Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 TrakCel Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  72. 6.12.5 TrakCel Recent Developments
  73. 6.13 Stafa Cellular Therapy
  74. 6.13.1 Stafa Cellular Therapy Company Information
  75. 6.13.2 Stafa Cellular Therapy Business Overview
  76. 6.13.3 Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  78. 6.13.5 Stafa Cellular Therapy Recent Developments
  79. 6.14 McKesson
  80. 6.14.1 McKesson Company Information
  81. 6.14.2 McKesson Business Overview
  82. 6.14.3 McKesson Cell and Gene Therapy Supply Chain and Logistics Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 McKesson Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  84. 6.14.5 McKesson Recent Developments
  85. 6.15 BioLife Solutions
  86. 6.15.1 BioLife Solutions Company Information
  87. 6.15.2 BioLife Solutions Business Overview
  88. 6.15.3 BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  90. 6.15.5 BioLife Solutions Recent Developments
  91. 6.16 Patheon
  92. 6.16.1 Patheon Company Information
  93. 6.16.2 Patheon Business Overview
  94. 6.16.3 Patheon Cell and Gene Therapy Supply Chain and Logistics Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Patheon Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  96. 6.16.5 Patheon Recent Developments
  97. 6.17 SF Express
  98. 6.17.1 SF Express Company Information
  99. 6.17.2 SF Express Business Overview
  100. 6.17.3 SF Express Cell and Gene Therapy Supply Chain and Logistics Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 SF Express Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  102. 6.17.5 SF Express Recent Developments
7 North America
  1. 7.1 North America Cell and Gene Therapy Supply Chain and Logistics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Cell and Gene Therapy Supply Chain and Logistics Market Size by Country (2021-2026)
  3. 7.3 North America Cell and Gene Therapy Supply Chain and Logistics Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Cell and Gene Therapy Supply Chain and Logistics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Cell and Gene Therapy Supply Chain and Logistics Market Size by Country (2021-2026)
  3. 8.3 Europe Cell and Gene Therapy Supply Chain and Logistics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Cell and Gene Therapy Supply Chain and Logistics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Cell and Gene Therapy Supply Chain and Logistics Market Size by Country (2021-2026)
  3. 10.3 South America Cell and Gene Therapy Supply Chain and Logistics Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst